INCY
Incyte
Health Care
Biotechnology
Wilmington, Delaware
Balance Sheet 32 Accounts • 5 Years
| Account | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets - CashAndCashEquivalents | $1.7B | $3.2B | $3.0B | $2.1B | $1.5B |
| Assets - Inventories | $58.9M | $63.0M | $42.0M | $27.9M | $16.4M |
| Assets - PrepaidExpensesAndOtherCurrentAssets | $168.9M | $182.8M | $167.0M | $126.3M | $60.1M |
| Assets - TotalCurrentAssets | $3.2B | $4.6B | $4.1B | $3.1B | $2.4B |
| Assets - Property,PlantAndEquipment | $763.4M | $751.5M | $739.3M | $723.9M | $559.6M |
| Assets - Goodwill | $155.6M | $155.6M | $155.6M | $155.6M | $155.6M |
| Assets - DeferredTaxAssets | $800.1M | $672.1M | $500.5M | $507.9M | $25.0M |
| Assets - FinanceLeaseAssets | $30.8M | $25.5M | $26.3M | $27.5M | $28.5M |
| Assets - OtherNoncurrentAssets | $10.8M | $52.1M | $25.4M | $37.3M | $39.4M |
| Assets - TotalAssets | $5.4B | $6.8B | $5.8B | $4.9B | $3.6B |
| Liabilities - AccountsPayable | $197.5M | $109.6M | $277.5M | $172.1M | $98.8M |
| Liabilities - AccruedLiabilities | $1.2B | $935.6M | $701.1M | $533.6M | $378.4M |
| Liabilities - OperatingLeaseLiabilitiesCurrent | $5.6M | $5.7M | $8.2M | $10.6M | $12.7M |
| Liabilities - FinanceLeaseLiabilitiesCurrent | $4.4M | $3.4M | $3.2M | $2.6M | $2.3M |
| Liabilities - ContingentConsiderationLiabilityCurrent | $39.2M | $38.4M | $36.5M | $37.0M | $38.4M |
| Liabilities - OtherCurrentLiabilities | $58.9M | $73.3M | $68.4M | $45.8M | $35.1M |
| Liabilities - TotalCurrentLiabilities | $1.6B | $1.2B | $1.2B | $854.3M | $631.2M |
| Liabilities - OperatingLeaseLiabilitiesNoncurrent | $16.8M | $14.3M | $14.1M | $15.6M | $14.2M |
| Liabilities - FinanceLeaseLiabilitiesNoncurrent | $33.5M | $29.2M | $30.1M | $31.6M | $32.6M |
| Liabilities - DeferredTaxLiabilitiesNoncurrent | $38.0M | $40.2M | $42.6M | $40.4M | $23.0M |
| Liabilities - ContingentConsiderationLiabilityNoncurrent | $153.8M | $173.6M | $184.5M | $207.0M | $227.6M |
| Liabilities - OtherNoncurrentLiabilities | $167.5M | $149.2M | $99.2M | $70.4M | $58.3M |
| Liabilities - TotalLiabilities | $2.0B | $1.6B | $1.5B | $1.2B | $949.6M |
| Equity - PreferredStock | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M |
| Equity - CommonStock | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K |
| Equity - RetainedEarnings(deficit) | $-1.1B | $160.4M | $-437.2M | $-777.9M | $-1.7B |
| Equity - AccumulatedOtherComprehensiveIncome(loss) | $-13.1M | $13.1M | $15.1M | $-19.5M | $-15.4M |
| Equity - TotalStockholdersEquity | $3.4B | $5.2B | $4.4B | $3.8B | $2.6B |
| Equity - TotalLiabilitiesAndStockholdersEquity | $5.4B | $6.8B | $5.8B | $4.9B | $3.6B |
| Equity - TotalLiabilitiesandEquity | $5.4B | $6.8B | $5.8B | $4.9B | $3.6B |
| Validation - L+E Components Sum Difference | $0 | $0 | $0 | $0 | $0 |